Back
Monte Rosa Therapeutics Stock Predictions
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
10
GLUE
Monte Rosa Therapeutics
Last Price:
$5.66
Seasonality Move:
-3.86%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]Monte Rosa Therapeutics Stock Forecast
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 22.4% based on the past 3 years of stock performance.
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Monte Rosa Therapeutics Stock Undervalued?The current Monte Rosa Therapeutics [GLUE] share price is $5.66. The Score for GLUE is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Monte Rosa Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 22.4% based on the past 3 years of stock performance.
Monte Rosa Therapeutics Stock Rating
Sell
10
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics overpriced?
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Monte Rosa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monterosatx.com
52-Week Data
52-Week High:
12.40
52-Week Low:
3.21
Prediction Charts
Market Cap:
347.4M
Price in USD:
5.66
Volume:
631.1K
Beta:
1.51
Technical Analysis
SMA50:
7.93
SMA100:
6.98
SMA200:
5.89
52-Wk Change:
6.9%
Stock Predictions
-
Is Monte Rosa Therapeutics stock public?Yes, Monte Rosa Therapeutics is a publicly traded company.
-
What is the Monte Rosa Therapeutics stock quote today?The Monte Rosa Therapeutics stock price is 5.66 USD today.
-
How to buy Monte Rosa Therapeutics stock online?You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-27 | 7.15 | 7.06 | 7.32 | 6.86 |
| Dec-30 | 6.95 | 7.02 | 7.16 | 6.77 |
| Dec-31 | 7.15 | 6.94 | 7.38 | 6.87 |
| Jan-2 | 7.04 | 7.11 | 7.34 | 6.88 |
| Jan-3 | 7.28 | 7.17 | 7.46 | 7.09 |
| Jan-6 | 7.23 | 6.89 | 7.30 | 6.88 |
| Jan-7 | 6.86 | 6.53 | 7.10 | 6.30 |
| Jan-8 | 6.42 | 5.99 | 6.48 | 5.98 |
| Jan-10 | 5.81 | 5.70 | 5.89 | 5.40 |
| Jan-13 | 5.69 | 5.66 | 5.70 | 5.38 |
| Jan-14 | 5.73 | 5.56 | 5.97 | 5.49 |
| Jan-15 | 6.03 | 6.24 | 6.38 | 5.77 |
| Jan-16 | 6.19 | 5.76 | 6.21 | 5.51 |
| Jan-17 | 5.79 | 5.66 | 5.91 | 5.55 |
Monte Rosa Therapeutics Earnings
Monte Rosa Therapeutics Earnings Report: Per Share Monte Rosa Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monte Rosa Therapeutics Forecast Revenue Growth
Monte Rosa Therapeutics Stock Analysis: Historical quarterly revenues per share for Monte Rosa Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.